Amgen (AMGN) Prepaid Assets (2009 - 2026)

Amgen (AMGN) posted quarterly Prepaid Assets of $4.1 billion for Q1 2026, up 26.24% year-over-year from $3.3 billion in Q1 2025, and little changed on a QoQ basis from $4.1 billion in Q4 2025.

Amgen (AMGN) Prepaid Assets (2009 - 2026) Analysis & Trends

Amgen (AMGN) has reported Prepaid Assets for 18 consecutive years, with $4.1 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 26.24% year-over-year to $4.1 billion; the TTM figure through Mar 2026 stood at $4.1 billion (up 26.24% YoY), while the FY2025 annual figure was $4.1 billion, up 26.12% from the prior year.
  • Prepaid Assets came in at $4.1 billion for Q1 2026 at Amgen, roughly flat from $4.1 billion in the prior quarter.
  • The five-year high for Prepaid Assets was $4.1 billion in Q4 2025, with the low at $2.3 billion in Q2 2022.
  • Average Prepaid Assets over 5 years is $3.0 billion, with a median of $2.8 billion recorded in 2024.
  • Across the five-year window, Prepaid Assets fell 6.81% in 2022 and climbed 28.06% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $2.4 billion in 2022, then rose by 8.96% to $2.6 billion in 2023, then increased by 25.94% to $3.3 billion in 2024, then rose by 26.12% to $4.1 billion in 2025, then declined by 0.48% to $4.1 billion in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $4.1 billion, $4.1 billion, and $3.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.11 Bn
Dec 31, 2025 4.13 Bn
Sep 30, 2025 3.60 Bn
Jun 30, 2025 3.42 Bn
Mar 31, 2025 3.26 Bn
Dec 31, 2024 3.28 Bn
Sep 30, 2024 3.08 Bn
Jun 30, 2024 2.98 Bn
Mar 31, 2024 2.82 Bn
Dec 31, 2023 2.60 Bn
Sep 30, 2023 2.57 Bn
Jun 30, 2023 2.32 Bn
Mar 31, 2023 2.40 Bn
Dec 31, 2022 2.39 Bn
Sep 30, 2022 2.50 Bn
Jun 30, 2022 2.26 Bn
Mar 31, 2022 2.49 Bn
Dec 31, 2021 2.37 Bn
Sep 30, 2021 2.54 Bn
Jun 30, 2021 2.42 Bn